40th Anniversary of SÁÁ – Hilton Reykjavík Nordica, October 2-4, 2017 
| Min. | Tuesday October 3rd |
| Session Chair – Ingunn Hansdóttir PhD, Chief Psycologist at SÁÁ | |
| 03:55 | Opening, honorary remarks – Óttarr Proppé, Minister of Health |
| 47:57 | Addiction Is a Chronic Brain Disease – What We Know Today – Nora D. Volkow, MD, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) |
| 29:57 | Treating Addiction in General Medical Settings: From Research to Policy – Patrick G. O’Connor, MD, MPH, Professor of General Medicine, Chief, General Internal Medicine, Yale School of Medicine |
| 23:36 | SÁÁ ́s 40 years of addiction treatment – Þórarinn Tyrfingsson MD, past Medical Director at SÁÁ |
| 21:12 | New patterns in addiction in Finland and challenges for the addiction treatment system – Kaarlo Simojoki MD, PhD, Chief Medical Officer of the A-Clinic Foundation |
| 22:58 | What We Know & Don’t Know About Technology for Assessment, Pharmacotherapy and Contingency Management? – David R. Gastfriend, MD, DFASAM, Chief Architect, CONTINUUM – The ASAM Criteria Decision Engine™; Chief Medical Officer & Co-Founder, DynamiCare Health, Inc.; Scientific Advisor, Treatment Research Institute |
| Session Chair – Berglind Guðmundsdóttir Chief Psychologist LSH, Assistant Professor of HI | |
| 19:22 | International research on addiction treatment – George Woody MD, Professor, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania |
| 15:03 | Estimation of community drug abuse in the Reykjavík metropolitan area by wastewater analysis – Arndís Sue Ching Löve PhD student MS Pharm |
| 28:45 | Developments in prescription opioids in the Nordics and Norway and trends in overdose deaths – Thomas Clausen Professor, Dr. Med, University of Oslo |
| 14:57 | Opioid epidemic in the US – Patrick G. O ́Connor, MD, MPH, Professor of General Medicine, Chief, General Internal Medicine, Yale School of Medicine |
| 15:20 | Opioid addiction in Iceland SÁÁ – Valgerður Rúnarsdóttir, MD, Medical Director at SÁÁ |
| Seminar: Cannabis | |
| 38:45 | Cannabis and society – can science guide public policies? – Nora Volkow, MD, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) |
| 29:18 | Medicinal Marijuana, Policy and Physician – Gregory Bunt, MD FISAM, President, International Society of Addiction Medicine Diplomate, American Board of Psychiatry and Neurology, Clinical Assistant Professor of Psychiatry, NYU School of Medicine, New York, NY |
| 12:50 | Cannabis addiction in Iceland – Þórarinn Tyrfingsson MD, past Medical Director at SÁÁ |
| 33:31 | Panel discussion: Gerður Aaagot MD general practitioner, Rafn Magnús Jónsson, Project Manager at the Directorate of Health, politicians and policy makers and other interested parties. |
| Min. | Tuesday October 3rd |
| Seminar: Genetics of Addiction | |
| 29:06 | Genes, brain and behavior. The Decode SÁÁ research collaboration: what have we learned? – Kári Stefánsson, MD, Decode Genetics |
| 52:55 | Genes, brain and behavior. The Decode SÁÁ research collaboration: what have we learned? – Thorgeir Thorgeirsson, PhD, Decode Genetics |
| 27:17 | New approaches to developing medications for helping smokers quit – Frank J. Vocci, PhD, President, Friends Research Institute |
| Seminar: Viral infections and addiction, HIV and Hepatitis C | |
| 03:42 | Epidemiology of hepatitis C and HIV in Iceland -Þórólfur Guðnason MD, PhD, Chief Epidemiologist, Centre for Health Security and Communicable Disease Control, Directorate of Health |
| 20:54 | A Structural Intervention to Improve Substance Abuse Diagnosis and Treatment Practices in HIV Clinic Settings. Treatment Adherence through the Advanced Use of Technology, preliminary findings – Judith A. Aberg, MD, FIDSA, FACP, Professor of Medicine, Chief, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai |
| 09:30 | A Structural Intervention to Improve Substance Abuse Diagnosis and Treatment Practices in HIV Clinic Settings. Treatment Adherence through the Advanced Use of Technology, preliminary findings – Erna Milunka Kojic MD, professor at Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai |
| 18:42 | Treatment as prevention for hepatitis C (TraP HepC): A nationwide elimination program in Iceland – Sigurður Ólafsson, MD, FACP, Director of Hepatology, Division of Gastroenterology, Department of Medicine Landspitali University Hospital |
| 21:39 | Treating Hepatitis C in RI ́s prisons – Josiah D. Rich, MD, MPH, Professor of Brown University, RI |
| Session Chair – Reynir Arngrímsson, MD, President elect IMA, Professor of Genetic Medicine | |
| 16:43 | Telemedicine in Clinical Care and as a tool in addiction medicine – Andrew H. Talal, MD, MPH, School of Medicine and Biomedical Sciences, University at Buffalo, New York |
| 24:23 | The complexities of managing people with addictions – Jeffrey Goldsmith MD, DLFAPA, DFASAM, past president of ASAM |
| 28:01 | Physicians with substance use disorder: Can this model be effectively applied to other populations? – Paul Earley MD, DFASAM, Medical Director of the Georgia Professionals Health Program, in the U.S. |
| Seminar: Training of professionals in addiction medicine | |
| 04:47 | Addiction Medicine: Full specialty for doctors in Norway – Thomas Clausen Professor, Dr. Med, University of Oslo |
| 26:33 | Addictions Nursing: What it is, and why it matters – Stephen Strobbe PhD, RN, PMHCNS-BC, CARN-AP, FIAAN, Clinical Associate Professor, University of Michigan School of Nursing, President (2016-2018), International Nurses Society on Addictions (IntNSA) |
| 21:45 | Physicians: What is needed to get board certified in addiction the US today – Jeffrey Goldsmith MD, DLFAPA, DFASAM |
| 30:22 | Counsellors: What is needed to get certified as an addiction counsellor in the US today – Gerard J. Schmidt, MA, LPC, MAC, President of NAADAC, The Association for Addiction Professionals and the Chief Operations Officer at Valley HealthCare System in Morgantown WV |
| 34:41 | Panel discussions: Lecturers and professionals in addiction, offcials, program directors – Thomas Clausen Professor, Dr. Med, University of Oslo. Dr. Steinunn Hrafnsdóttir, Associate professor, Faculty of Social Work, School of Social Sciences, University of Iceland. Gisli Kort Kristofersson, PHD, RN, PMHNP-BC Assistant Professor, School of Health Sciences, University of Akureyri, Hjalti Þór Björnsson, NCAC, program director at SAA |
